NASDAQ: GLSI
Greenwich Lifesciences Inc Stock Ownership - Who owns Greenwich Lifesciences?

Insider buying vs selling

Have Greenwich Lifesciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Snehal PatelCEO and CFO2025-04-253,600$9.88
$35.57kBuy
Snehal PatelCEO and CFO2025-04-175,400$8.98
$48.49kBuy
Snehal PatelCEO and CFO2025-04-073,600$9.10
$32.76kBuy
Snehal PatelCEO and CFO2025-04-045,500$8.73
$48.02kBuy
Snehal PatelCEO and CFO2025-01-102,500$12.51
$31.28kBuy
Snehal PatelCEO and CFO2025-01-071,800$13.75
$24.75kBuy
Snehal PatelCEO and CFO2025-01-061,100$13.31
$14.64kBuy
Snehal PatelCEO and CFO2025-01-033,400$12.95
$44.03kBuy
Snehal PatelCEO and CFO2025-01-022,000$11.97
$23.94kBuy
Snehal PatelCEO and CFO2024-12-312,400$11.36
$27.26kBuy

1 of 2

GLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GLSI insiders and whales buy or sell their stock.

GLSI Shareholders

What type of owners hold Greenwich Lifesciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Snehal Patel70.53%9,613,078$107.95MInsider
Kinnary Patel9.75%1,329,590$14.93MInsider
Kenneth Hallock5.83%794,308$8.92MInsider
David McWilliams4.55%620,301$6.97MInsider
Blackrock Inc2.69%367,181$4.12MInstitution
Eric Rothe2.30%313,226$3.52MInsider
Vanguard Group Inc1.97%269,002$3.02MInstitution
Jaye Thompson1.94%264,148$2.97MInsider
Geode Capital Management LLC1.02%138,982$1.56MInstitution
Frank Joseph Daugherty0.66%90,121$1.01MInsider

1 of 3

GLSI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GLSI8.64%91.36%Net Buying
BHST0.62%0.00%
CLYM73.63%9.49%Net SellingNet Selling
SGMO16.98%10.66%Net SellingNet Selling
THTX25.96%0.00%

Greenwich Lifesciences Stock Ownership FAQ

Who owns Greenwich Lifesciences?

Greenwich Lifesciences (NASDAQ: GLSI) is owned by 9.04% institutional shareholders, 95.56% Greenwich Lifesciences insiders, and 0.00% retail investors. Snehal Patel is the largest individual Greenwich Lifesciences shareholder, owning 9.61M shares representing 70.53% of the company. Snehal Patel's Greenwich Lifesciences shares are currently valued at $107.95M.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.